Eurobio Scientific (XPAR:ALERS) Total Liabilities : €141.2 Mil (As of Dec. 2023)

View and export this data going back to 2005. Start your Free Trial

What is Eurobio Scientific Total Liabilities?

Eurobio Scientific's Total Liabilities for the quarter that ended in Dec. 2023 was €141.2 Mil.

Eurobio Scientific's quarterly Total Liabilities declined from Dec. 2022 (€157.75 Mil) to Jun. 2023 (€138.00 Mil) but then increased from Jun. 2023 (€138.00 Mil) to Dec. 2023 (€141.16 Mil).

Eurobio Scientific's annual Total Liabilities increased from Dec. 2021 (€49.00 Mil) to Dec. 2022 (€157.75 Mil) but then declined from Dec. 2022 (€157.75 Mil) to Dec. 2023 (€141.16 Mil).

Eurobio Scientific Total Liabilities Historical Data

The historical data trend for Eurobio Scientific's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eurobio Scientific Total Liabilities Chart

Eurobio Scientific Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

44.44

64.45

49.00

157.75

141.16

Eurobio Scientific Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Total Liabilities	Get a 7-Day Free Trial															49.00	45.11	157.75	138.00	141.16

Eurobio Scientific Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Eurobio Scientific's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	52.878	+	(86.249	+	2.029
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	141.2

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	316.329	-	175.173
	=	141.2

Eurobio Scientific's Total Liabilities for the quarter that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	52.878	+	(86.249	+	2.029
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	141.2

Total Liabilities	=	Total Assets (Q: Dec. 2023 )	-	Total Equity (Q: Dec. 2023 )
	=	316.329	-	175.173
	=	141.2

Eurobio Scientific Total Liabilities Related Terms

Thank you for viewing the detailed overview of Eurobio Scientific's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Eurobio Scientific (XPAR:ALERS) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Eurobio Scientific (XPAR:ALERS) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

E8TN:Germany

Address

63-65 Boulevard Massena, Paris, FRA, 75013

Website

http://www.exonhit.com

Eurobio Scientific is one of the leading providers of specialty in vitro diagnostics and life-science solutions. The product portfolio includes Tetanos Quick Stick, BJI InoPlex, AlloMap, and TEDAC Consortium.

Eurobio Scientific (XPAR:ALERS) Headlines

No Headlines